Log In
Print this Print this

hTERT DNA cancer vaccine (INO-1400)

  Manage Alerts
Collapse Summary General Information
Company Inovio Pharmaceuticals Inc.
DescriptionDNA cancer vaccine targeting human telomerase reverse transcriptase (hTERT) delivered using Inovio's Cellectra intradermal electroporation device
Molecular Target Telomerase reverse transcriptase (TERT)
Mechanism of Action 
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today